Jensen B A
Klinisk immunologisk afdeling & blodbanken, Hvidovre Hospital, København.
Ugeskr Laeger. 1992 Mar 23;154(13):846-9.
It cannot be anticipated that the increasing requirements for blood and blood components will be covered by proportionate expansion in gross supply. Blood component therapy, i.e. specific substitution of clinically important deficiencies, is recommended. In addition to being clinically rational, this principle of treatment provides enhanced utilization of resources, product quality and transfusion safety. By reviewing the literature, an unjustified excess of blood ordering and crossmatching was demonstrated in elective surgery. Practical application of Type and Screen (T&S) and thorough revision of preoperative blood ordering policies are safe and resource-saving measures, and guidelines such as these are proposed.
无法预期血液及血液成分需求的不断增加会由总供应量的相应扩大来满足。推荐采用血液成分疗法,即针对临床上重要的缺乏症进行特异性替代治疗。这种治疗原则除了具有临床合理性外,还能提高资源利用效率、产品质量和输血安全性。通过文献回顾发现,择期手术中存在不合理的过度备血和交叉配血现象。血型鉴定和筛查(T&S)的实际应用以及对术前备血政策的全面修订是安全且节省资源的措施,并提出了此类指导原则。